Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #142455 on Biotech Values
DewDiligence
05/23/12 9:06 PM
#142482 RE: NP1986 #142455
genisi
05/24/12 10:01 AM
#142520 RE: NP1986 #142455
AFAIK that would typically include an oxaliplatin-based regimen followed by an irinotecan-based regimen, or vice versa.